Climb Bio, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 20 WILLIAM STREET, WELLESLEY HILLS, MA, 02481
Mailing Address 20 WILLIAM STREET, WELLESLEY HILLS, MA, 02481
Phone 1-866-857-2596
Fiscal Year End 1231
EIN 832273741
Financial Overview
FY2024
-$35.12M
Net Income
$5.31M
Total Liabilities
$128.72M
Stockholders' Equity
$93.11M
Cash & Equivalents
$-1.53
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 8-K Current report of material events | December 31, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | December 15, 2025 | View on SEC |
| 4 Insider stock transaction report | December 15, 2025 | View on SEC |
| 8-K Current report of material events | December 11, 2025 | View on SEC |
Material Events
8-K Legal Issue December 31, 2025
High Impact
- Climb Bio, Inc. filed a lawsuit against Alumis Inc. and its subsidiary Acelyrin, Inc.
- The lawsuit seeks a court declaration that Climb Bio does not owe a milestone payment related to the drug 'budoprutug'.
Insider Trading
STRONG BUY 1 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.